For health reform to be a success, employers must continue to provide healthcare benefits
WASHINGTON-For health reform to be a success, employers must continue to-or in the case of small firms, begin to-provide healthcare benefits to employees. To this end, the Department of Health and Human Services (HHS) has been rolling out incentives for employer-based coverage.
The incentives are especially designed for the many small companies that have found health benefits too costly. Tax credits are available this year to help small firms pay health insurance premiums, and HHS recently made subsidies available to cover some costs of coverage for early retirees.
Evidence is emerging that these incentives might have an impact, particularly on small firms and individuals that are most in need of assistance.
Somewhat surprising, a survey of employer health benefits unveiled by the Kaiser Family Foundation a few weeks ago indicates a rise in the number of firms offering health benefits in 2010. The main increase involved very small firms; 59% of companies with fewer than 10 workers now provide coverage, up from 46% last year. The Health Research & Educational Trust (HRET) conducted the annual survey for the foundation.
Even though this kind of change actually affects very few workers, the increase could be a sign that small employers will respond positively to tax credits and other initiatives that reduce the cost of coverage.
Heidi Whitmore, a study co-author and senior research scientist at the National Opinion Research Center, says it's plausible that more firms are offering coverage. However, she speculates that many small firms that do not offer health benefits have gone out of business in the recession and skewed the numbers. The HRET study has tracked benefit data for 12 years.
A Commonwealth Fund report calculates that the tax credit for small companies authorized by the Patient Protection and Affordable Care Act (PPACA) may help more than 16 million employees obtain coverage. The credits are available this year to help small firms offset some of the cost of health insurance premiums, and the Congressional Budget Office estimates that the program could provide $40 billion in support over the next decade. The credit is modest and not everyone is eligible, according to Janet Trautwein, executive vice president of the National Association of Health Underwriters. But, she adds, the credit "provides an incentive for small employers to stay in the game."
While the credits and other incentives may spur employers to retain coverage for the next few years, the big question is whether these strategies will continue to have that effect after state-based health insurance exchanges emerge in 2014.
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More